0.5 Mg Dactinomycin Injection USP

Name: 0.5 Mg Dactinomycin Injection USP
Brand: NEETCO BIOPHARMA
Price: 250 INR
Availability: InStock

Price 250 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

0.5 Mg Dactinomycin Injection USP Specification

Salt Composition
Dactinomycin 0.5 mg/vial

Indication
Treatment of Wilms tumor, rhabdomyosarcoma, Ewings sarcoma, and metastatic testicular cancer

Dosage Form
Injection

Feature
Sterile, preservative-free, single-dose vial

Ingredients
Dactinomycin, excipients, sterile water for injection

Application

Ph Level
4.5 - 7.0

Physical Color/Texture
Orange crystalline powder (before reconstitution), clear solution (after reconstitution)

Fermentation Smell
Odorless

Storage Instructions
Store between 2C to 8C, protect from light

Shelf Life
24 months

Reconstitution
Reconstitute with 1.1 mL sterile water for injection

Packaging Type
Glass vial, individually packed in a carton

Vial Size
0.5 mg per vial

Precautions
For hospital and oncology use only; handle as cytotoxic agent

Approval
FDA and Indian FDA approved

Contraindications
Hypersensitivity to dactinomycin or any ingredient in the formulation

Route of Administration
Intravenous (IV)

Prescription Required
Yes

About 0.5 Mg Dactinomycin Injection USP

Discover the splendid efficacy of 0.5 Mg Dactinomycin Injection USP, a top-tier anti-cancer agent trusted by redoubtable hospitals and oncology centers worldwide. Each sterile glass vial, standardized at 0.5 mg, ensures preservative-free, single-dose administration via intravenous route. Shop Now to secure a product in demand, offered with competitive pricing for distributors, exporters, suppliers, and traders across India. FDA and Indian FDA approved, this orange crystalline powder (reconstituted to clear solution) is ideal for treating Wilms tumor, rhabdomyosarcoma, Ewing's sarcoma, and metastatic testicular cancer. Prescription required for hospital use only.

Therapeutic Applications and Uses

0.5 Mg Dactinomycin Injection USP is used as an advanced anti-cancer therapy. Its redoubtable action is specifically indicated for Wilms tumor, rhabdomyosarcoma, Ewing's sarcoma, and metastatic testicular cancer. The injection is dispensed for hospital and oncology center use, making it a valuable asset for healthcare providers treating patients with difficult malignancies. Commercially, it is supplied throughout India to specialists and facilities aiming to deliver top-tier chemotherapeutic care.

Premium Delivery, Valuation, and Packaging Standards

Experience premium delivery with secure orange crystalline powder vials carefully packed in cartons, ensuring product integrity in transit. Valuation for each consignment is competitive and tailored for large-scale hospital and clinical orders. Payment terms are flexible, and sample vials are available upon request for evaluation. With proper packaging and adherence to strict storage instructions (2C to 8C, protected from light), distributors can rely on prompt, efficient supply and robust shelf life of 24 months.

FAQ's of 0.5 Mg Dactinomycin Injection USP:

Q: How should the 0.5 Mg Dactinomycin Injection USP be reconstituted for use?

A: Reconstitute the vial by adding 1.1 mL of sterile water for injection, resulting in a clear solution suitable for intravenous administration.

Q: What types of cancers is this injection indicated for?

A: This injection is specifically used in the treatment protocols for Wilms tumor, rhabdomyosarcoma, Ewing's sarcoma, and metastatic testicular cancer.

Q: When is Dactinomycin Injection USP contraindicated?

A: The injection is contraindicated in patients with hypersensitivity to dactinomycin or any ingredient in the formulation. It should only be administered in hospital or oncology settings.

Q: Where should the vials be stored to maintain efficacy?

A: Store the glass vials between 2C to 8C in a location protected from light to preserve product stability and potency for up to 24 months.

Q: What is the benefit of using single-dose, preservative-free vials?

A: Single-dose, preservative-free vials reduce the risk of contamination and ensure accurate dosing, aligning with sterile hospital protocols for cytotoxic agents.